These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 8852543)

  • 1. The potential role of calcium antagonists in the management of congestive heart failure: initial experience with lacidipine.
    de Vries RJ; Dunselman PH
    J Cardiovasc Pharmacol; 1995; 25 Suppl 3():S33-9. PubMed ID: 8852543
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of lacidipine on peak oxygen consumption, neurohormones and invasive haemodynamics in patients with mild to moderate chronic heart failure.
    de Vries RJ; Dunselman PH; Chin Kon Sung UG; van Veldhuisen DJ; Corbeij HM; van Gilst WH; Lie KI
    Heart; 1996 Feb; 75(2):159-64. PubMed ID: 8673754
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The dual endothelin receptor antagonist tezosentan acutely improves hemodynamic parameters in patients with advanced heart failure.
    Schalcher C; Cotter G; Reisin L; Bertel O; Kobrin I; Guyene TT; Kiowski W
    Am Heart J; 2001 Aug; 142(2):340-9. PubMed ID: 11479476
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The calcium channel blocker felodipine attenuates the positive hemodynamic effects of the beta-blocker metoprolol in severe dilated cardiomyopathy--a prospective, randomized, double-blind and placebo-controlled study with invasive hemodynamic assessment.
    Braun M; Edelmann F; Knapp M; Schön S; Schwencke C; Simonis G; Borst M; Weinbrenner C; Strasser RH
    Int J Cardiol; 2009 Feb; 132(2):248-56. PubMed ID: 18579230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of amlodipine and lacidipine on heart rate variability in hypertensive patients with stable angina pectoris and isolated left ventricular diastolic dysfunction.
    Zaliūnas R; Brazdzionyte J; Zabiela V; Jurkevicius R
    Int J Cardiol; 2005 Jun; 101(3):347-53. PubMed ID: 15907400
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of lacidipine, a new long-lasting calcium antagonist, in elderly hypertensive patients.
    Rizzini P; Castello C; Salvi S; Recchia G
    J Cardiovasc Pharmacol; 1991; 17 Suppl 4():S38-43; discussion S43-4. PubMed ID: 1726005
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Converting-enzyme inhibitor therapy for chronic heart failure.
    Massie BM; Kramer BL; Topic N
    Herz; 1983 Apr; 8(2):71-80. PubMed ID: 6343210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as bolus in refractory congestive heart failure: long-term effects.
    Licata G; Di Pasquale P; Parrinello G; Cardinale A; Scandurra A; Follone G; Argano C; Tuttolomondo A; Paterna S
    Am Heart J; 2003 Mar; 145(3):459-66. PubMed ID: 12660669
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of oral lacidipine on cardiopulmonary function at rest and during exercise in normal subjects.
    Gulotta C; Torchio R; Greco-Lucchina P; Calabrese G
    J Cardiovasc Pharmacol; 1991; 17 Suppl 4():S55-8. PubMed ID: 1726009
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A Czech and Slovak interventional study of spirapril (the CASSIS study). A randomized, double-blind, multicenter, placebo-controlled study in chronic heart failure].
    Jerie P; Kremer HJ; Uhlír O; Widimský J
    Vnitr Lek; 1997 Jun; 43(6):351-8. PubMed ID: 9601863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Calcium antagonists and treatment of chronic heart failure].
    Lanfranchi J
    Arch Mal Coeur Vaiss; 1995 Apr; 88(4 Suppl):623-31. PubMed ID: 7487313
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of lisinopril on serum catecholamine concentrations both at rest and on exercise in patients with congestive cardiac failure. A double blind, placebo controlled, parallel group study.
    Fahy G; Deb B; Robinson K; Graham I
    Ir Med J; 1993; 86(4):134-5. PubMed ID: 8395488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exercise-induced modifications in cardiorespiratory parameters of hypertensive patients treated with calcium antagonists.
    Fariello R; Boni E; Corda L; Muiesan ML; Agabiti-Rosei E
    J Hypertens Suppl; 1991 Dec; 9(3):S67-72. PubMed ID: 1686784
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Calcium antagonists in the treatment of heart failure. Re-evaluation of therapeutic strategies].
    Gattis W; O'Connor CM
    Drugs; 2000; 59 Spec No 2():17-24. PubMed ID: 11002855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Role of calcium antagonists in the pharmacologic treatment of heart insufficiency].
    de Sá ME
    Rev Port Cardiol; 1989; 8(7-8):547-52. PubMed ID: 2698718
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
    Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bradykinin contributes to the systemic hemodynamic effects of chronic angiotensin-converting enzyme inhibition in patients with heart failure.
    Cruden NL; Witherow FN; Webb DJ; Fox KA; Newby DE
    Arterioscler Thromb Vasc Biol; 2004 Jun; 24(6):1043-8. PubMed ID: 15105283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of lacidipine, a novel dihydropyridine calcium antagonist, on carbohydrate and lipid metabolism.
    Spieker C; Zidek W
    J Cardiovasc Pharmacol; 1995; 25 Suppl 3():S23-6. PubMed ID: 8852541
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessing the treatment of congestive heart failure: inotropic agents and calcium channel blockers.
    Hilleman DE
    Pharmacotherapy; 1993; 13(5 Pt 2):88S-93S. PubMed ID: 7901842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multicenter, randomized, double-blind, placebo-controlled study on the effect of oral tolvaptan on left ventricular dilation and function in patients with heart failure and systolic dysfunction.
    Udelson JE; McGrew FA; Flores E; Ibrahim H; Katz S; Koshkarian G; O'Brien T; Kronenberg MW; Zimmer C; Orlandi C; Konstam MA
    J Am Coll Cardiol; 2007 Jun; 49(22):2151-9. PubMed ID: 17543634
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.